Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 9 | History Defined

How backlash to the pandemic helped shape Trump’s health picks - Roll Call

Cabinet health picks include vaccine skeptics, supporters of herd immunity and promoters of hydroxychloroquine to treat COVID-19.

Roll Call

Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump

Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics warn it may hinder patient access and innovation.

Benzinga

Dr. Oz's finanical conflicts of interest

Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Here’s one way to slash Britain’s rate of child poverty: stop dithering and make all fathers pay what’s due

A new report shows a bad situation is getting worse. This really is a case for draconian action from the state, says Guardian columnist Polly Toynbee

The Guardian - UK

Maximus Secures Medicare Contract Through 2031, Shares Gain Momentum

Maximus announces CMS has canceled the early re-procurement of its Medicare contract, allowing the company to continue its current work until 2031.

Benzinga

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.

The Independent UK

White House rule would expand coverage of anti-obesity drugs - Roll Call

It’s unclear whether incoming President Donald J. Trump will support outgoing President Joe Biden’s plan to insure the weight loss drugs.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

Trump Picks Dr. Oz as Head of Medicare and Medicaid

President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.

Kiplinger

What Are Wall Street Analysts' Target Price for CMS Energy Stock?

CMS Energy has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Barchart

How Dr. Oz could change Medicare under President Trump

What you might expect from Oz if he runs Medicare, Medicaid, and management of the Affordable Care Act at the 6,000-person CMS.

Fortune

Dr. Mehmet Oz Nominated For CMS Administrator By President-Elect Trump

Senator Fetterman supports Dr. Oz's nomination for CMS administrator, emphasizing bipartisan cooperation for healthcare policies.

Top News

Dr. Mehmet Oz Chosen As CMS Administrator By President-Elect Trump

President-elect Trump selects Dr. Oz to lead CMS, focusing on healthcare reform and wellness promotion.

Roll Call

Trump taps Dr. Oz to serve as Medicare, Medicaid administrator - Roll Call

President-elect Trump's health team would include former TV talk show host Mehmet Oz as head of Medicare and Medicaid.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Medicare Part B is getting more expensive and outpacing inflation. Here's what you can expect to pay in 2025

The increase “is mainly due to projected price changes and assumed utilization increases that are consistent with historical experience,” according to the Centers for Medicare and Medicaid.

International Business Times UK

Medicare Part B Premium Hike Outpaces 2025 Social Security COLA, Tightening Seniors' Monthly Budgets

Medicare Part B Premiums will increase by 5.9% to $185 monthly, which will be deducted from Social Security checks starting January 2025.

Roll Call

Biden wants Medicaid doctors to talk to parents about firearms - Roll Call

Supporters hope the announcement allows conversations about gun safety to become as routine as talks about other safety issues impacting kids.

Kiplinger

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.

Upcoming changes to the Part D drug benefit, including a $2,000 cap on out-of-pocket medication, will benefit millions of Americans. But higher premiums may also be on the way

Fortune

How to use Medicare star ratings wisely during Open Enrollment

The star ratings offer a shorthand look at how plans measure up for quality and member experience.

Latin Times

Republicans' Mass Deportation Plan Threatens Nearly 5 Million U.S. Families, Report Warns

Mass deportations could slash some household incomes by 48%, disrupt local economies, and leave 5.5 million U.S.-born children at risk.

Barchart

Here's What to Expect From CMS Energy's Next Earnings Report

CMS Energy will release its third-quarter earnings this month, and analysts anticipate a double-digit bottom-line growth.

1 … 8 9 10 11

People

Chiquita BrooksLaSure

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.